Overview Randomized Trial in Adult Subjects With Acute Migraines Status: Completed Trial end date: 2021-10-22 Target enrollment: Participant gender: Summary The purpose of this study is to test the safety and efficacy of BHV-3500 versus placebo in the acute treatment of moderate or severe migraine. Phase: Phase 3 Details Lead Sponsor: Biohaven Pharmaceuticals, Inc.